Figure 3.
Comparison of Kaplan-Meier product limit estimate of event-free survival (EFS) between the good-risk group (group A: WBC count, < 5 × 109/L; platelet count, > 20 × 109/L) and the rest (group B).
Comparison of Kaplan-Meier product limit estimate of event-free survival (EFS) between the good-risk group (group A: WBC count, < 5 × 109/L; platelet count, > 20 × 109/L) and the rest (group B).
